Sumangalam Formulations Profile
Key Indicators
- Authorised Capital ₹ 3.50 Cr
as on 16-11-2024
- Paid Up Capital ₹ 3.41 Cr
as on 16-11-2024
- Company Age 11 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.00 Cr
as on 16-11-2024
- Revenue -77.24%
(FY 2023)
- Profit -115.94%
(FY 2023)
- Ebitda -83.28%
(FY 2023)
- Net Worth -4.13%
(FY 2023)
- Total Assets -21.18%
(FY 2023)
About Sumangalam Formulations
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.50 Cr and a paid-up capital of Rs 3.41 Cr.
The company currently has active open charges totaling ₹5.00 Cr.
Harishkumar Joshi and Truptiben Joshi serve as directors at the Company.
- CIN/LLPIN
U24100GJ2013PTC075029
- Company No.
075029
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 May 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Sumangalam Formulations Private Limited offer?
Sumangalam Formulations Private Limited offers a wide range of products and services, including Dyes & Color Additives, Pigment Emulsion, Pigments, Industrial Fabrics and Textiles, Industrial Fabric.
Who are the key members and board of directors at Sumangalam Formulations?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Harishkumar Joshi  | Director | 13-May-2013 | Current |
| Truptiben Joshi | Director | 24-Mar-2018 | Current |
Financial Performance and Corporate Structure Insights of Sumangalam Formulations.
Sumangalam Formulations Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 77.24% decrease. The company also saw a substantial fall in profitability, with a 115.94% decrease in profit. The company's net worth dipped by a decrease of 4.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sumangalam Formulations?
In 2023, Sumangalam Formulations had a promoter holding of 49.96% and a public holding of 50.04%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ashlesha Solutions Private LimitedActive 7 years 9 monthsHarishkumar Joshi and Truptiben Joshi are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of Baroda Creation Date: 20 Jun 2014 | ₹5.00 Cr | Open |
How Many Employees Work at Sumangalam Formulations?
Sumangalam Formulations has a workforce of 8 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sumangalam Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sumangalam Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
